Dividend Assets Capital’s Takeda Pharmaceutical TAK Stock Holding History

Dividend Assets Capital’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,536	Closed	-$36K	–	343
2023 Q4	$36K	Sell	2,536 -670	-21%	-$9.51K	0.01%	279
2023 Q3	$50K	Sell	3,206 -8,600	-73%	-$133K	0.01%	262
2023 Q2	$185K	Sell	11,806 -923	-7%	-$15.1K	0.04%	170
2023 Q1	$199K	Hold	12,729	–	–	0.04%	162
2022 Q4	$199K	Sell	12,729 -1,257	-9%	-$17.6K	0.04%	162
2022 Q3	$181K	Hold	13,986	–	–	0.04%	166
2022 Q2	$196K	Sell	13,986 -125	-0.9%	-$1.78K	0.04%	173
2022 Q1	$202K	Hold	14,111	–	–	0.04%	180
2021 Q4	$192K	Hold	14,111	–	–	0.04%	187
2021 Q3	$231K	Sell	14,111 -503	-3%	-$8.44K	0.05%	174
2021 Q2	$246K	Buy	14,614 +8,600	+143%	+$146K	0.05%	171
2021 Q1	$110K	Sell	6,014 -168	-3%	-$3.02K	0.02%	221
2020 Q4	$113K	Buy	+6,182	New	+$108K	0.02%	212
2020 Q2	–	Sell	-25,062	Closed	-$380K	–	193
2020 Q1	$380K	Sell	25,062 -9,432	-27%	-$171K	0.09%	116
2019 Q4	$681K	Sell	34,494 -17,777	-34%	-$340K	0.11%	113
2019 Q3	$899K	Sell	52,271 -17,322	-25%	-$300K	0.14%	97
2019 Q2	$1.23M	Sell	69,593 -21,730	-24%	-$395K	0.2%	94
2019 Q1	$1.86M	Buy	+91,323	New	+$1.84M	0.3%	76

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dividend Assets Capital's TAK Position: Q1 2024 in Review

Dividend Assets Capital sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 2,536 shares — an estimated $36K sold.

Dividend Assets Capital first reported a position in TAK in Q1 2019 and held it in 18 quarters. The position peaked at $1.86M in Q1 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

Dividend Assets Capital reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
Dividend Assets Capital sold 2,536 Takeda Pharmaceutical shares in Q1 2024, an estimated $36K.
Dividend Assets Capital first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 18 quarters.
Dividend Assets Capital's Takeda Pharmaceutical position peaked at $1.86M in Q1 2019.
313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Dividend Assets Capital's 13F filing for Q1 2024, filed 15 May 2024.